Point-of-care testing (POCT) technology
has made major breakthroughs
in community medicine and physician office situations, in tandem with
the more ubiquitous and intensive usage of highly integrated quick
detection equipment for illness diagnosis, personal care, and mobile
healthcare. Although the photoelectrochemical (PEC)-based POCT platform
offers the benefits of cheap cost and good user engagement, its commercialization
is still limited by the photodetection components’ downsizing
and mobility, among other factors. In this work, a novel highly integrated
PEC biosensor aided by piezophototronics to enhance the efficiency
of PEC testing was reported for flexible detection of cancer-associated
antigens in biological fluids (prostate-specific antigen, PSA, used
as an example). Multiple signal enhancement strategies, including
a magnetic bead-linked enzyme-linked immune system catalyzing the
production of ascorbic acid from the substrate and a piezoelectric-assisted
enhancement strategy, were used for sensitive detection of the analyte
to be tested in human body fluids. Unlike the electron transfer mechanism
in heterojunctions, piezoelectric semiconductors promote the transfer
of electrons and holes by generating piezoelectric potentials in the
ultrasonic field, thus contributing to the performance of the PEC
testbed. Under optimized conditions, the test platform achieves good
correspondence for PSA at 0.02–40 ng mL–1. Impressively, the test devices are comparable to or even superior
to gold standard ELISA kits in terms of cost approval and batch testing.
This research demonstrates the potential of piezoelectric semiconductors
for POC applications in revolutionary PECs and offers innovative thoughts
for the development of new PEC bioanalytical components.